According to the Navadhi Global Peptide Therapy Market Strategic Research Report 2026-2031 Asia-Pacific is the fastest-growing region at 17.07% CAGR, driven by China's 140 million diabetics, Japan's post-PMDA approvals of Ozempic and Wegovy, and India emerging as the fastest-growing sub-market at 19.89% CAGR, leveraging GLP-1 biosimilar production
During pregnancy Blood sugar targets in pregnancy are more stringent than outside of pregnancy
A large randomized trial showed significant improvement in adult NASH patients receiving vitamin E therapy at a dosage of 533.6 mg/day for 96 weeks
Medications that may lower your B12 levels Believe it or not, the medications you take for other conditions might be robbing you of your B12
Full for longer even though I only eat small amounts
A large 'All of Us' analysis suggests people with current GLP-1 prescriptions drink less often, although the observational findings do not prove that the drugs reduce alcohol use
